This study characterizes a novel high‐risk (HR) subgroup of Ph‐like ALL, which comprises a combination of IKZF1 dysregulation and activated oncogenes related to Ph‐like ALL, which stratifies patients with Ph‐like ALL into higher‐ and lower‐risk categories. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.